A. D. Culverwell
Leeds Teaching Hospitals NHS Trust
Internal medicineRadiologyPET-CTOncologyTomographyPositron emission tomographyDiseaseMalignancyPositron Emission Tomography-Computed TomographyFDG-Positron Emission TomographyColonic CarcinomaNuclear medicineRectal carcinomaIn patientAdvanced diseaseFdg pet ctCt technique2 18f fluoro 2 deoxy d glucoseColorectal cancerComputed tomographyMedicine
2Publications
2H-index
79Citations
Publications 2
Newest
#1A. D. Culverwell (Leeds Teaching Hospitals NHS Trust)H-Index: 2
#2Fahmid U. Chowdhury (Leeds Teaching Hospitals NHS Trust)H-Index: 18
Last. Andrew Scarsbrook (Leeds Teaching Hospitals NHS Trust)H-Index: 29
view all 3 authors...
Recent treatment advances now allow a realistic chance of cure in selected patients with metastatic colorectal carcinoma (CRC). Accurate pre-treatment staging is crucial to ensure appropriate management by identification of patients with more advanced disease who will not benefit from surgery. 18Fluorine 2-fluoro-2-deoxy-d-glucose positron emission tomography–computed tomography (PET–CT) has a firmly established role in staging, restaging, and recurrence detection of a range of tumors. This arti...
10 CitationsSource
#1A. D. Culverwell (Leeds Teaching Hospitals NHS Trust)H-Index: 2
#2Andrew Scarsbrook (Leeds Teaching Hospitals NHS Trust)H-Index: 29
Last. Fahmid U. Chowdhury (Leeds Teaching Hospitals NHS Trust)H-Index: 18
view all 3 authors...
With the increasing utilization of integrated positron-emission tomography/computed tomography (PET/CT) using the glucose analogue 2-[18F]-fluoro-2-deoxy- d- glucose (FDG) in oncological imaging, it is important for radiologists and nuclear medicine physicians to be aware that FDG uptake is not specific for malignancy, as many different physiological variants and benign pathological conditions can also exhibit increased glucose metabolism. Such false-positive FDG uptake often arises outside the ...
64 CitationsSource